PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Elissa Weinberg, MD, BSc, CCFP, FCFP - Improving Glycemic Control in Adults With Type 2 Diabetes: A Need for Change
Visit https://www.peervoice.com/NND860 to view the entire programme with slides. After completing “Elissa Weinberg, MD, BSc, CCFP, FCFP - Improving Glycemic Control in Adults With Type 2 Diabetes: A Need for Change”, participants will be able to: Outline the mechanism of action of GLP-1 receptor agonists (RA) and the dual-acting glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs; Discuss the latest evidence with GIP/GLP-1 RAs in the treatment of type 2 diabetes (T2D); Identify patients with T2D who may benefit from these therapies; and Propose strategies to optimize use of GIP/GLP-1 RAs, such as addressing side effects, drug interactions, and patient education.